top of page

Ten years of self-testing: From the vein to the upper arm

Writer: Dr. Reiner Kraft
Dr. Reiner Kraft
2 hours ago
8 min read
Ten years of self-testing: From the vein to the upper arm

Blood test at home: What I've learned in ten years of self-testing


A little over ten years ago, my health wasn't good. High blood pressure, too much stress, too much weight. My body was clearly telling me: You have to do something. I started to delve deeply into cellular metabolism, mitochondria, epigenetics, and the microbiome. Not out of academic interest, but because I wanted to use it for myself.


The first question wasn't what I should change. The first question was: How do I even measure where I stand? Without measurement, it's all guesswork. Blood tests were the intuitive answer. But how to get good blood test results without going to the doctor every three months—that occupied me for the next ten years.


In this article, I'll tell you about my journey. Four phases, each with a problem that led me to the next. And finally, what I now use as standard practice: a blood test at home, on the upper arm, without a needle in the vein.



Phase 1: Serum, whole blood and the issue with veins


Serum levels are important for many things: lipids, liver, kidneys, thyroid, inflammation, vitamin D.

But I quickly reached a limit when it came to nutrient deficiencies. Many minerals, such as magnesium, zinc, or selenium, are found within the cells, not in the serum. To see this, you need a whole blood mineral analysis.


And it's a venous procedure. So, doctor's appointment, needle. Every three to four months if you really want to see the progress. That takes its toll on the veins. Anyone who, like me, doesn't have many easily accessible veins notices it clearly after a few years. At some point, you're sitting there thinking: There has to be a better way.



Phase 2: Laser spectroscopy, non-invasive, but no blood values


The next step was laser spectroscopy. Non-invasive, fast, and it provides an initial indication of the direction to work in. I worked with it for several years and learned a great deal.


But I was honest with myself: This isn't diagnostics in the conventional sense. These aren't blood test results. Anyone wanting to dose a dietary supplement or document a progress is stuck again. The question remained: How do I get real lab results, regularly, without a doctor's visit and without a vein?



Phase 3: Capillary blood, the criticism and the hemolysis problem


About a year ago, I started experimenting: What can be done with capillary blood? That is, blood from the tiny vessels directly under the skin, collected in a microtube and sent by mail to a laboratory. For this, I collaborated with a laboratory in the Berlin area, LabClinic, which specializes in precisely this type of capillary blood diagnostics.


The criticism came immediately. "That's not accurate enough." "That's impossible." And yes, there is the case of Theranos in the USA: A start-up raised billions with finger-prick tests and ultimately delivered false results to patients. The only peer-reviewed independent study showed 12.2 percent of results outside the reference range, compared to 7.5 and 8.3 percent at two established laboratories [15].


The lesson here is not "capillary blood doesn't work". The lesson is: Anyone using capillary blood must publish their validation and not promise more than the sample provides [16].


Because the research findings are now clear.


In the largest finger-prick study, 30 of 33 routine values were within the desired margin of error; only glucose was an outlier [1]. Using serum gel tubes, 37 of 39 values met the criteria [2]. Lipids, including ApoB and Lp(a), HbA1c, liver, kidney, TSH, ferritin, B12, and CRP are equivalent [1, 2, 3, 4]. Capillary vitamin D levels are 6 to 11 percent lower; the laboratory must be aware of this [1, 2]. Potassium and fasting glucose should still be measured intravenously [1, 6, 20].


For those who want to delve deeper: I have written down the research findings in a separate article, marker by marker.


The real problem was something else, and I experienced it myself: hemolysis. When you prick your finger, tissue is crushed, red blood cells rupture, and values like AST, potassium, or LDH become unusable. In 120 patients who pricked their own fingers, the hemolysis index was almost twice as high as with venous blood, and only 64 percent of the samples were usable for potassium, compared to 95 percent previously [7]. Hemolysis skews values even at concentrations invisible to the naked eye [8]. Then there's the volume: at home, only 44 percent of participants in one study filled both tubes correctly [6]. And the feedback from my clients was clear: finger pricking isn't for everyone. According to a meta-analysis, needle phobia affects 20 to 30 percent of young adults [12].


The analysis of the capillary blood was sound. Getting it into the test tube was the problem.



Phase 4: Tasso, the at-home blood test on the upper arm



Tasso, the at-home blood test on the upper arm

We recently started working with Tasso. Tasso is a device from Seattle, developed in 2011 at the University of Wisconsin-Madison, with 18 US patents granted, FDA approved since 2022 and CE marked since 2023 [17, 21, 22].


Here's how it works: You stick the device to your upper arm like a plaster and press the button. A tiny lancet pierces the skin in less than a second, a slight vacuum draws the blood through an open channel into the tube. You wait a moment, the tube fills with 600 to 800 microliters, and that's it. No squeezing, no second prick, and honestly, you hardly feel it [5, 17].


The studies confirm this impression. In direct comparison with venipuncture, the concordance coefficients for liver function tests were above 0.99, 92 percent of patients reported less pain, and 94 percent would prefer the device in the future [5]. In 452 blood draws, the median pain score was 1 compared to 2 for venipuncture on a scale of 0 to 10 [13]. Problems occurred in 6 percent of blood draws from the upper arm and in 28 percent from the fingertip [14]. Centrifuged serum in the gel tube remains stable for over 24 hours even at 30 degrees Celsius [9].


For me, this is the way forward. From 600 to 800 microliters, I can get a wide range of serum values, and whole blood values are also possible. This can be done every three months, at home, and it doesn't damage the veins. After ten years of searching, it feels like I've finally found the right solution.



My standard practice from now on


That's why I'm now using EVER Precision as the standard for my clients in my epigenetics practice. Not because it's my own product, but because it meets the four criteria I've learned over ten years: reliable, non-invasive, convenient for home use, and sustainable for the veins.


This is how it is structured:


  1. Blood: the basic panel. 29 serum values, collected at home using Tasso. Lipids including ApoB and Lp(a), liver, kidney, thyroid, iron status, B12, folate, vitamin D, inflammation, and more. This is the foundation upon which everything else is built. Included in the EVER Precision Membership .

  2. DNA. Just like I've been doing for years: first, understand your genetic predispositions, for example, regarding nutrient absorption, detoxification, or susceptibility to inflammation. The DNA panel is available as an add-on to the membership.

  3. Microbiome. The third data source that completes the picture. The microbiome add-on also serves as a supplement. Those who want everything together can opt for the DNA + microbiome + consultation package .

  4. Classification: AI plus humans. The initial assessment is just the first step. Our AI, the EVER Guide, which we developed specifically for this purpose, performs the initial classification. The expert evaluation is then carried out by an advisory team: I am part of it myself, along with other EVER experts, currently two doctors who are deeply involved in the subject. This applies to both the results and the resulting supplement routine.

  5. Supplement routine: Baseline plus measurement. We distinguish between a baseline, which is generally always useful, even without measurement. Based on this, we then adjust the dosage according to the results: what do we add, what do we omit, and what do we change in dosage? Anyone who wants to discuss this personally can book an appointment. Consultation, 60 minutes .

  6. Implementation: the EVER app. Routine, reminders, history. The EVER app in the App Store This helps to track everything in everyday life until the next retest after three or six months.


Acceptance, classification, routine, implementation. That's the cycle I sought for myself ten years ago. Today I can offer it to my clients without anyone having to come to the practice or have a needle inserted into a vein.



Black Friday: Get a better deal until November 30th


If you want to join now: Until November 30, 2026, the EVER Shop offers Black Friday prices that are automatically deducted in the shopping cart, without a code.


product

Regular

Black Friday

EVER Precision Membership (Basic Panel, Report, Expert Plan, App)

€365 / year

€329 in the first year

DNA panel (add-on to membership)

€649

€549

Microbiome (Add-on to Membership)

€189

€149

€985

€885

Consultation 60 minutes (Add-on to Membership)

€240

€240

DNA analysis, microbiome analysis, packages, and consultations require an active membership. All offers are listed under Black Friday & Bestsellers. in the EVER Shop.



Sources


  1. Doeleman MJH et al. Comparison of capillary finger stick and venous blood sampling for 34 routine chemistry analytes. Clin Chem Lab Med 2025;63(4):747-752. PMID 39565982. doi:10.1515/cclm-2024-0812

  2. DiPasquale C et al. Equivalence between capillary blood and venous blood test results using miniaturized assays and novel collection methods to support routine bloodwork. J Appl Lab Med 2025;10(5):1090-1104. PMID 40387130. doi:10.1093/jalm/jfaf059

  3. Geujar R et al. Validation of (self-collected) capillary blood using a topper collection system for 15 common clinical chemistry analytes. Clin Chem Lab Med 2025;63(11):2209-2217. doi:10.1515/cclm-2025-0148

  4. Nathan DM et al. Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies. PLoS One 2021;16(11):e0257154. PMID 34780485. doi:10.1371/journal.pone.0257154

  5. Wickremsinhe E et al. Standard venipuncture vs a capillary blood collection device for the prospective determination of abnormal liver chemistry. J Appl Lab Med 2023;8(3):535-550. PMID 36533519. doi:10.1093/jalm/jfac127

  6. Hoekstra J et al. At-home blood collection for clinical chemistry analyzes in a kidney transplant population: a feasibility study. Clin Chem Lab Med 2026;64(4):855-865. doi:10.1515/cclm-2025-1199

  7. van den Brink N et al. Self-sampling of blood using a topper and pediatric tubes: prospective feasibility study for PSA analysis in 120 prostate cancer patients. Clin Chem Lab Med 2023;61(12):2159-2166. doi:10.1515/cclm-2023-0272

  8. Lippi G et al. Influence of hemolysis on routine clinical chemistry testing. Clin Chem Lab Med 2006;44(3):311-316. PMID 16519604. doi:10.1515/CCLM.2006.054

  9. Iacovetti G et al. Assessment of the stability of 20 biochemical analytes in serum and whole blood samples after storage at nonstandard temperatures. Pract Lab Med 2026;48:e00514. PMID 41503054. doi:10.1016/j.plabm.2025.e00514

  10. Lee I et al. Postprandial capillary-venous glucose gradient in type 1 diabetes: magnitude and clinical associations in a real world setting. Diabet Med 2016;33(7):998-1003. PMID 26536491. doi:10.1111/dme.13025

  11. González A et al. Capillary blood in core laboratories: current and future challenges. Clin Chem Lab Med 2026;64(4):752-766. doi:10.1515/cclm-2025-0888

  12. McLenon J, Rogers MAM. The fear of needles: a systematic review and meta-analysis. J Adv Nurs 2019;75(1):30-42. PMID 30109720. doi:10.1111/jan.13818

  13. Dasari H et al. Feasibility, acceptability, and safety of a novel device for self-collecting capillary blood samples in clinical trials. PLoS One 2024;19(5):e0304155. PMID 38809872. doi:10.1371/journal.pone.0304155

  14. Solheim SA et al. No pain, just gain: painless, easy, and fast dried blood spot collection from fingertip and upper arm in doping control. Drug Test Anal 2021;13(10):1783-1790. PMID 34346172. doi:10.1002/dta.3135

  15. Kidd BA et al. Evaluation of direct-to-consumer low-volume lab tests in healthy adults. J Clin Invest 2016;126(5):1734-1744. PMID 27018593. doi:10.1172/JCI86318

  16. Fiala C, Diamandis EP. The meteoric rise and dramatic fall of Theranos: lessons learned for the diagnostic industry. Clin Chem Lab Med 2018;56(9):1443-1446. doi:10.1515/cclm-2018-0353

  17. US FDA. 510(k) K221131, Tasso+ (Decision August 12, 2022, Product Code FMK, 21 CFR 878.4850). 510(k) Summary

  18. Royal College of Pathologists. Self-sampling at the point of care: enhancing access, improving care. Bulletin, July 2025. rcpath.org

  19. CLSI. GP42-Ed7: Collection of Capillary Blood Specimens. 7th edition, 2020. clsi.org

  20. DDG/DGKL. Statement on Rili-BÄK Table B1.1 (Glucose, Potassium), February 4, 2025. ddg.info

  21. Justia Patents. Patents assigned to Tasso, Inc. patents.justia.com

  22. Tasso Inc., Press Release, September 19, 2023. Tasso+ receives CE marking. businesswire.com

 
 
 

Comments


  • Instagram
  • Facebook
  • LinkedIn
  • YouTube

Have you subscribed to my newsletter yet? Every 1 to 2 weeks I send out tips and information for a healthier life. You can subscribe here.

 

Disclaimer and general information on medical topics

The content presented here is for informational and educational purposes only. It does not constitute a recommendation or endorsement of the diagnostic methods, treatments, or medications described or mentioned. The texts make no claim to completeness, nor can the accuracy, timeliness, or balance of the information provided be guaranteed. These texts are in no way a substitute for professional medical advice from a doctor or pharmacist and should not be used as a basis for self-diagnosis or for starting, changing, or stopping any treatment for illnesses. Always consult your doctor if you have any health questions or concerns. Dr. Kraft Lifestyle & Longevity GmbH accepts no liability for any inconvenience or damage resulting from the use of the information presented here. Please also refer to the general disclaimer in the legal notice .

©2026 Dr. Kraft Lifestyle & Longevity GmbH - Impressum und Datenschutz

bottom of page